Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
90.93 EUR | +0.14% | +0.78% | +1.31% |
05-22 | Bristol Myers, Sanofi liability in Hawaii Plavix case grows to $916 million | RE |
05-21 | Sanofi Partners with Microsoft-Backed OpenAI, Formation Bio to Develop Drugs with AI | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.31% | 123B | |
+38.32% | 723B | |
+34.54% | 595B | |
-2.76% | 369B | |
+20.62% | 332B | |
+2.76% | 282B | |
+17.21% | 244B | |
+9.64% | 208B | |
-4.62% | 205B | |
+0.42% | 168B |
- Stock Market
- Equities
- SAN Stock
- News Sanofi
- Sanofi, GSK Target COVID-19 Vaccine Availability in Late-2022 After New Positive Late-stage Data